Category: Healthcare

  • A Tower Debuts

    The opening of the Friese Household Tower on the Windfall Cedars-Sinai Tarzana Medical Middle is simply across the nook. Forward of the deliberate Oct. 1 opening, the tower held a family and friends preview on Aug. 26 to have fun the tower, which has an expanded emergency division, 150 non-public affected person rooms and advanced-care…

  • MPulse’s Tech Has Medicaid in Thoughts

    Since April 1, hundreds of thousands of low-income People have been thrown off the rolls of Medicaid, the government-sponsored well being plan for the poor, as Covid-era protections expired and folks have been required to re-enroll or lose their protection. And in line with a research from the Kaiser Household Basis, practically three-fourths of these…

  • Hospitals Get High Scores for High quality

    Three San Fernando Valley-area hospitals have acquired five-star high quality ranking from the federal Facilities for Medicare and Medicaid Companies company. The hospitals – Glendale Adventist Medical Middle, Northridge Hospital Medical Middle and Windfall Holy Cross Medical Middle in Mission Hills – positioned within the high ranks of the company’s annual quality-ratings survey launched final…

  • Amgen CEO Decries Federal Deliberations

    Robert Bradway, chief govt of Thousand Oaks pharma big Amgen Inc., has grown more and more pissed off on the authorities’s unwillingness to return to phrases with Amgen over its $27.8 billion acquisition deal of Irish pharma firm Horizon Therapeutics. That deal, introduced final December, hit a significant stumbling block in Could when the Federal…

  • Agency’s Tech Receives Peer Evaluation Nod

    Northridge-based SpineX Inc., a clinical-stage firm creating noninvasive neuromodulation units, has had a few of its analysis printed in a peer-reviewed journal because it gears up for scientific trials of a tool to deal with cerebral palsy. SpineX, which was based in 2018, has been creating a tool that’s positioned in a affected person’s spinal…

  • Simulations Plus Buys Immunetrics

    Lancaster-based Simulations Plus Inc., which supplies modeling and simulation software program and providers for pharmaceutical merchandise, is buying Pittsburgh-based Immunetrics Inc., one other modeling and simulation firm targeted on accelerating drug growth in oncology, immunology and autoimmune illnesses. Below the phrases of the settlement introduced on June 20, Simulations Plus agreed to pay the shareholders…

  • Hashish-Centric DNA Take a look at Lands U.S. Patent

    Burbank-based genetic testing firm Endocanna Well being Inc. has acquired a United States patent for its DNA take a look at that analyzes a person’s cannabinoid neuron system to find out whether or not any hashish merchandise could trigger adverse impacts. In response to Endocanna Well being, the patent award, which it introduced this month,…

  • Avita Shares Leap After FDA Motion

    Shares of Valencia-based skin-treatment firm Avita Medical Inc. rose 16% within the two buying and selling classes following the corporate’s June 8 announcement that it had received Meals and Drug Administration approval for expanded use of its regenerative skin-cell remedy. Avita Medical has developed a drug platform it calls Recell, which extracts sure regenerative cells…

  • A2 Biotherapeutics Begins ‘Tmod’ Drug Scientific Trials

    Agoura Hills-based biotech firm A2 Biotherapeutics Inc. has begun scientific trials for the primary drug derived from its cell remedy drug platform; the drug goals to deal with sufferers with colorectal, pancreatic and non-small cell lung cancers. The corporate introduced on Might 30 it had begun dosing its first affected person within the preliminary scientific…

  • Might FTC Amgen Lawsuit Have Ripple Impact?

    This text has been revised and up to date from the unique model. A Federal Commerce Fee lawsuit in search of a preliminary injunction to dam biopharmaceutical big Thousand Oaks-based Amgen Inc. from buying a smaller Irish pharmaceutical firm is using a decades-old antitrust enforcement concept that has observers questioning whether or not biotech and biopharma firms…